{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:32:01Z","timestamp":1760239921642,"version":"build-2065373602"},"reference-count":64,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["NCT02603146"],"award-info":[{"award-number":["NCT02603146"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.rdc.2022.06.011","type":"journal-article","created":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:07:10Z","timestamp":1664582830000},"page":"931-943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting Environmental Risks to Prevent Rheumatic Disease"],"prefix":"10.1016","volume":"48","author":[{"given":"Kevin D.","family":"Deane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2022.06.011_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/art.41417","article-title":"Rheumatoid arthritis pathogenesis, prediction, and prevention: an emerging paradigm shift","volume":"73","author":"Deane","year":"2021","journal-title":"Arthritis Rheum"},{"issue":"16","key":"10.1016\/j.rdc.2022.06.011_bib2","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.rdc.2022.06.011_bib3","doi-asserted-by":"crossref","first-page":"e0214202","DOI":"10.1371\/journal.pone.0214202","article-title":"Autoantibodies are present before the clinical diagnosis of systemic sclerosis","volume":"14","author":"Burbelo","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.rdc.2022.06.011_bib4","doi-asserted-by":"crossref","first-page":"102579","DOI":"10.1016\/j.jaut.2020.102579","article-title":"Anti-neutrophil cytoplasmic antibodies predate symptom onset of ANCA-associated vasculitis. a case-control study","volume":"117","author":"Berglin","year":"2021","journal-title":"J\u00a0Autoimmun"},{"issue":"2","key":"10.1016\/j.rdc.2022.06.011_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/annrheumdis-2017-212763","article-title":"Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study","volume":"78","author":"Gerlag","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.rdc.2022.06.011_bib6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/ard.2008.105767","article-title":"Effect of dexamethasone on autoantibody levels and arthritis development in patients with arthralgia: a randomised trial","volume":"69","author":"Bos","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.011_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001591","article-title":"Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial","volume":"7","author":"van Boheemen","year":"2021","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.011_bib8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s13063-019-3403-7","article-title":"Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol","volume":"20","author":"Al-Laith","year":"2019","journal-title":"Trials"},{"issue":"suppl 10","key":"10.1016\/j.rdc.2022.06.011_bib10","article-title":"Abatacept Reverses Subclinical Arthritis in Patients with High-risk to Develop Rheumatoid Arthritis -results from the Randomized, Placebo-controlled ARIAA Study in RA-at Risk Patients [Abstract 0455]","volume":"73","author":"Rech","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2022.06.011_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/art.41417","article-title":"Rheumatoid Arthritis Pathogenesis, Prediction, and Prevention: An Emerging Paradigm Shift","volume":"73","author":"Deane","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.011_bib12","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1186\/s13063-018-3076-7","article-title":"Study of anti-malarials in incomplete lupus erythematosus (SMILE): study protocol for a randomized controlled trial","volume":"19","author":"Olsen","year":"2018","journal-title":"Trials"},{"issue":"3","key":"10.1016\/j.rdc.2022.06.011_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41584-019-0175-0","article-title":"Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition","volume":"15","author":"Scher","year":"2019","journal-title":"Nat Rev Rheumatol"},{"issue":"15","key":"10.1016\/j.rdc.2022.06.011_bib14","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.2106\/JBJS.M.01209","article-title":"Osteoarthritis: From Palliation to Prevention: AOA Critical Issues","volume":"96","author":"Chu","year":"2014","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.rdc.2022.06.011_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/oemed-2021-107899","article-title":"Dusty trades and associated rheumatoid arthritis in a population-based study in the coal mining counties of Appalachia","author":"Schmajuk","year":"2022","journal-title":"Occup Environ Med"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.011_bib16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s13075-020-02339-0","article-title":"The absolute risk of gout by clusters of gout-associated comorbidities and lifestyle factors-30 years follow-up of the Malmo Preventive Project","volume":"22","author":"Fatima","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"10.1016\/j.rdc.2022.06.011_bib17","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.autrev.2018.05.009","article-title":"Are we really what we eat? Nutrition and its role in the onset of rheumatoid arthritis","volume":"17","author":"Philippou","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.rdc.2022.06.011_bib18","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1136\/annrheumdis-2014-205459","article-title":"Being overweight or obese and risk of developing rheumatoid arthritis among women: a prospective cohort study","volume":"73","author":"Lu","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2022.06.011_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jbspin.2017.06.003","article-title":"Salt, inflammatory joint disease, and autoimmunity","volume":"85","author":"Sigaux","year":"2018","journal-title":"Joint Bone Spine"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.011_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13075-018-1680-2","article-title":"Mediterranean diet and risk of rheumatoid arthritis: a population-based case-control study","volume":"20","author":"Johansson","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2022.06.011_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/joim.13448","article-title":"The role of environmental exposures and gene-environment interactions in the etiology of systemic lupus erythematous","author":"Woo","year":"2022","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.rdc.2022.06.011_bib22","doi-asserted-by":"crossref","first-page":"j1794","DOI":"10.1136\/bmj.j1794","article-title":"The Dietary Approaches to Stop Hypertension (DASH) diet, Western diet, and risk of gout in men: prospective cohort study","volume":"357","author":"Rai","year":"2017","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.rdc.2022.06.011_bib23","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2310\/JIM.0b013e31821b8755","article-title":"Vitamin D and the immune system","volume":"59","author":"Aranow","year":"2011","journal-title":"J\u00a0Investig Med"},{"issue":"3","key":"10.1016\/j.rdc.2022.06.011_bib24","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00296-014-3185-x","article-title":"Diet and alcohol as risk factors for rheumatoid arthritis: a nested case-control study","volume":"35","author":"Sundstrom","year":"2015","journal-title":"Rheumatol Int"},{"issue":"12","key":"10.1016\/j.rdc.2022.06.011_bib25","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1136\/annrheumdis-2012-202127","article-title":"A\u00a0prediction rule for the development of arthritis in seropositive arthralgia patients","volume":"72","author":"van de Stadt","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.rdc.2022.06.011_bib26","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/BOR.0000000000000522","article-title":"Drug-induced lupus erythematosus: an update on drugs and mechanisms","volume":"30","author":"He","year":"2018","journal-title":"Curr Opin Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2022.06.011_bib27","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s10067-013-2245-z","article-title":"ANA (+) ANCA (+) systemic vasculitis associated with the use of minocycline: case-based review","volume":"32","author":"Lenert","year":"2013","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2022.06.011_bib28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/oxfordjournals.epirev.a000804","article-title":"Toxic oil syndrome: the perspective after 20 years","volume":"23","author":"Posada de la Paz","year":"2001","journal-title":"Epidemiol Rev"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.011_bib29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13643-021-01748-9","article-title":"Preventive interventions to reduce the burden of rheumatic heart disease in populations at risk: a systematic review protocol","volume":"10","author":"Shimanda","year":"2021","journal-title":"Syst Rev"},{"issue":"5","key":"10.1016\/j.rdc.2022.06.011_bib30","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/annrheumdis-2018-214514","article-title":"Prevotella copri in individuals at risk for rheumatoid arthritis","volume":"78","author":"Alpizar-Rodriguez","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"0","key":"10.1016\/j.rdc.2022.06.011_bib31","article-title":"Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis","volume":"2","author":"Scher","year":"2013","journal-title":"Elife"},{"key":"10.1016\/j.rdc.2022.06.011_bib32","article-title":"Antibody responses to epstein-barr virus in the preclinical period of rheumatoid arthritis suggest the presence of increased viral reactivation cycles","author":"Fechtner","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.rdc.2022.06.011_bib33","doi-asserted-by":"crossref","first-page":"587380","DOI":"10.3389\/fimmu.2020.587380","article-title":"Epstein-barr virus and systemic autoimmune diseases","volume":"11","author":"Houen","year":"2020","journal-title":"Front Immunol"},{"issue":"6578","key":"10.1016\/j.rdc.2022.06.011_bib34","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.rdc.2022.06.011_bib35","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41584-018-0070-0","article-title":"Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction","volume":"14","author":"Holers","year":"2018","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.011_bib36","doi-asserted-by":"crossref","first-page":"101473","DOI":"10.1016\/j.berh.2019.101473","article-title":"The microbiome in autoimmune rheumatic disease","volume":"34","author":"Konig","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.011_bib37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00432-021-03824-y","article-title":"Estimating the global burden of Epstein-Barr virus-related cancers","volume":"148","author":"Wong","year":"2022","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.rdc.2022.06.011_bib38","first-page":"CD012439","article-title":"Strategies to improve the implementation of workplace-based policies or practices targeting tobacco, alcohol, diet, physical activity and obesity","volume":"11","author":"Wolfenden","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"1007","key":"10.1016\/j.rdc.2022.06.011_bib39","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/pgmj.2008.076166","article-title":"Preventing type 2 diabetes: can we make the evidence work?","volume":"85","author":"Yates","year":"2009","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.rdc.2022.06.011_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2021-eular.1342","article-title":"Determining in which pre-arthritis stage HLA-shared epitope alleles and smoking exert their effect on the development of rheumatoid arthritis","author":"Wouters","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.rdc.2022.06.011_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/cells9020475","article-title":"The Impact of Cigarette Smoking on Risk of Rheumatoid Arthritis: A Narrative Review","volume":"9","author":"Ishikawa","year":"2020","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.rdc.2022.06.011_bib42","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/acr.23837","article-title":"Impact and timing of smoking cessation on reducing risk of rheumatoid arthritis among women in the nurses' health studies","volume":"71","author":"Liu","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.011_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.berh.2017.08.003","article-title":"Genetic and environmental risk factors for rheumatoid arthritis","volume":"31","author":"Deane","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.rdc.2022.06.011_bib44","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.rdc.2012.04.002","article-title":"Environmental and gene-environment interactions and risk of rheumatoid arthritis","volume":"38","author":"Karlson","year":"2012","journal-title":"Rheum Dis Clin North Am"},{"issue":"12","key":"10.1016\/j.rdc.2022.06.011_bib45","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41584-018-0097-2","article-title":"The microbiome and HLA-B27-associated acute anterior uveitis","volume":"14","author":"Rosenbaum","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.rdc.2022.06.011_bib46","doi-asserted-by":"crossref","first-page":"601518","DOI":"10.3389\/fimmu.2021.601518","article-title":"Spondyloarthritis and the Human Leukocyte Antigen (HLA)-B","volume":"12","author":"Kavadichanda","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.rdc.2022.06.011_bib47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41569-019-0258-2","article-title":"Genetics of rheumatic fever and rheumatic heart disease","volume":"17","author":"Muhamed","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.011_bib48","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/annrheumdis-2016-209154","article-title":"Omega-3 fatty acids are associated with a lower prevalence of autoantibodies in shared epitope-positive subjects at risk for rheumatoid arthritis","volume":"76","author":"Gan","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.rdc.2022.06.011_bib49","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/1756-185X.13143","article-title":"Diagnostic utility of HLA-B\u22175801 screening in severe allopurinol hypersensitivity syndrome: an updated systematic review and meta-analysis","volume":"20","author":"Yu","year":"2017","journal-title":"Int J Rheum Dis"},{"issue":"11","key":"10.1016\/j.rdc.2022.06.011_bib50","first-page":"730","article-title":"Evidence for the Prevention of Type 2 Diabetes Mellitus","volume":"118","author":"Shubrook","year":"2018","journal-title":"J\u00a0Am Osteopath Assoc"},{"issue":"8","key":"10.1016\/j.rdc.2022.06.011_bib51","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.2337\/dc09-0130","article-title":"Effectiveness of a pragmatic education program designed to promote walking activity in individuals with impaired glucose tolerance: a randomized controlled trial","volume":"32","author":"Yates","year":"2009","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.rdc.2022.06.011_bib52","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.pec.2018.12.011","article-title":"Effect of communicating personalized rheumatoid arthritis risk on concern for developing RA: A randomized controlled trial","volume":"102","author":"Marshall","year":"2019","journal-title":"Patient Educ Couns"},{"issue":"10","key":"10.1016\/j.rdc.2022.06.011_bib53","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/acr.23510","article-title":"Effectiveness of a web-based personalized rheumatoid arthritis risk tool with or without a health educator for knowledge of rheumatoid arthritis risk factors","volume":"70","author":"Prado","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"10.1016\/j.rdc.2022.06.011_bib54","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/acr.23411","article-title":"Disclosure of Personalized Rheumatoid Arthritis Risk Using Genetics, Biomarkers, and Lifestyle Factors to Motivate Health Behavior Improvements: A Randomized Controlled Trial","volume":"70","author":"Sparks","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.rdc.2022.06.011_bib55","doi-asserted-by":"crossref","first-page":"112376","DOI":"10.1016\/j.psychres.2019.04.025","article-title":"Implementation science: What is it and why should I care?","volume":"283","author":"Bauer","year":"2020","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.rdc.2022.06.011_bib56","article-title":"Predictors of interest in predictive testing for rheumatoid arthritis amongst first degree relatives of rheumatoid arthritis patients","author":"Wells","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.rdc.2022.06.011_bib57","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.clinthera.2019.04.015","article-title":"Preferences of Patients and At-risk Individuals for Preventive Approaches to Rheumatoid Arthritis","volume":"41","author":"Falahee","year":"2019","journal-title":"Clin Ther"},{"issue":"4","key":"10.1016\/j.rdc.2022.06.011_bib58","doi-asserted-by":"crossref","first-page":"e0216075","DOI":"10.1371\/journal.pone.0216075","article-title":"Preventing rheumatoid arthritis: Preferences for and predicted uptake of preventive treatments among high risk individuals","volume":"14","author":"Harrison","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.rdc.2022.06.011_bib59","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41927-018-0026-7","article-title":"Perspectives of patients, first-degree relatives and rheumatologists on preventive treatments for rheumatoid arthritis: a qualitative analysis","volume":"2","author":"Munro","year":"2018","journal-title":"BMC Rheumatol"},{"issue":"8","key":"10.1016\/j.rdc.2022.06.011_bib60","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11926-016-0598-4","article-title":"Preventive Treatments for Rheumatoid Arthritis: Issues Regarding Patient Preferences","volume":"18","author":"Finckh","year":"2016","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.011_bib61","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1186\/s13063-021-05682-y","article-title":"The effect of a multidisciplinary lifestyle program for patients with rheumatoid arthritis, an increased risk for rheumatoid arthritis or with metabolic syndrome-associated osteoarthritis: the \"Plants for Joints\" randomized controlled trial protocol","volume":"22","author":"Walrabenstein","year":"2021","journal-title":"Trials"},{"key":"10.1016\/j.rdc.2022.06.011_bib62","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1146\/annurev.publhealth.121208.131051","article-title":"Prevention trials: their place in how we understand the value of prevention strategies","volume":"31","author":"Colditz","year":"2010","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.rdc.2022.06.011_bib63","article-title":"Culinary medicine and culinary nutrition education for individuals with the capacity to influence health related behaviour change: A scoping review","author":"Asher","year":"2021","journal-title":"J\u00a0Hum Nutr Diet"},{"key":"10.1016\/j.rdc.2022.06.011_bib64","doi-asserted-by":"crossref","first-page":"e066452","DOI":"10.1136\/bmj-2021-066452","article-title":"Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial","volume":"376","author":"Hahn","year":"2022","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.rdc.2022.06.011_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/nu13103419","article-title":"Alcohol's Impact on the Cardiovascular System","volume":"13","author":"Roerecke","year":"2021","journal-title":"Nutrients"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X22000515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X22000515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:31:09Z","timestamp":1760182269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X22000515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0889857X22000515"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2022.06.011","relation":{},"ISSN":["0889-857X"],"issn-type":[{"type":"print","value":"0889-857X"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting Environmental Risks to Prevent Rheumatic Disease","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2022.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}